Variations of the proprotein convertase subtilisin/kexin type 9 gene in coronary artery disease

J Int Med Res. 2020 Jan;48(1):300060519839519. doi: 10.1177/0300060519839519. Epub 2019 Apr 5.

Abstract

Objective: Coronary artery disease (CAD) is the principal cause of mortality and morbidity worldwide. Studies have provided controversial results regarding whether variations in the proprotein convertase subtilisin/kexin type 9 gene (PCSK9) are risk factors for CAD. In this study, we evaluated the risk factors associated with PSCK9 genotypes and CAD in the Taiwanese population.

Methods: A total of 501 patients diagnosed with CAD by angiography and 334 CAD-free controls were recruited. Two single nucleotide polymorphisms of PSCK9 (rs505151 and rs529787) were genotyped.

Results: The prevalence of a positive family history for CAD was significantly higher in individuals carrying the AG + GG genotype of the PSCK9 rs505151 polymorphism. Among CAD patients with a positive family history, the prevalence of diabetes mellitus was significantly higher in those carrying the AG + GG genotype of the PSCK9 rs505151 polymorphism (73.3%) than in those carrying the AA genotype (39.2%).

Conclusion: In CAD patients, the AG genotype of PSCK9 rs505151 is associated with diabetes and a positive family history of CAD.

Keywords: Proprotein Convertase Subtilisin/Kexin Type 9; Taiwanese; coronary artery disease; diabetes; genotyping; polymorphisms.

MeSH terms

  • Aged
  • Coronary Artery Disease / enzymology*
  • Coronary Artery Disease / genetics*
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Genetic Variation*
  • Humans
  • Male
  • Polymorphism, Single Nucleotide / genetics
  • Proprotein Convertase 9 / genetics*

Substances

  • Proprotein Convertase 9